In the Boardroom - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

51 to 75 of 932 results

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

12-03-2014

When Merck & Co acquired Schering-Plough in 2009, the corporate real estate team reduced the combined…

ManagementMerck & CoMergers & AcquisitionsPharmaceutical

Australian Clinical Network Services opens new UK office and expands core services

10-03-2014

Australian product development company Clinical Network Services (CNS) has launched a new UK office headed…

AustraliaBiotechnologyBoardroomUK

GSK increases stake in Indian Pharma subsidiary to 75%

GSK increases stake in Indian Pharma subsidiary to 75%

10-03-2014

UK pharma giant GlaxoSmithKline says that, following the voluntary open offer undertaken by its Indian…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Moderna appoints biotechnology investment banking veteran Lorence Kim as chief financial officer

Moderna appoints biotechnology investment banking veteran Lorence Kim as chief financial officer

07-03-2014

US headquartered Moderna Therapeutics, a leader in the development of RNA (mRNA) Therapeutics has announced…

BoardroomModerna TherapeuticsPharmaceuticalUSA

Debiopharm to acquire products or companies to expand activities at Swiss manufacturing facility

06-03-2014

Swiss independent drug developer Debiopharm say it plans to expand and optimize activities at Debiopharm…

DebiopharmMergers & AcquisitionsPharmaceuticalProduction

Aquavit Pharmaceuticals appoints David Goldberg as chief medical officer

Aquavit Pharmaceuticals appoints David Goldberg as chief medical officer

06-03-2014

Aquavit Pharmaceuticals, a private US-based life science company, has announced the appointment of David…

BoardroomPharmaceuticalUSA

France’s AAA makes acquisition, gains orphan status for Gallium-68 DOTATATE

04-03-2014

French molecular nuclear medicines specialist Advanced Accelerator Applications SA (AAA) has acquired…

Advanced Accelerator ApplicationsGallium-68 DOTATATEMergers & AcquisitionsPharmaceuticalRegulation

Genticel appoints Dr Sophie Olivier as chief medical officer

04-03-2014

French biopharmaceutical company Genticel has recruited Sophie Olivier as chief medical officer to lead…

BiotechnologyBoardroomFrancePharmaceutical

Novogen appoints new board members and strategic advisor

Novogen appoints new board members and strategic advisor

04-03-2014

Australian biotech company Novogen has announced the appointments of new board members and a strategic…

AustraliaBiotechnologyBoardroomNovogenPharmaceutical

Oxford Gene Technology acquires Cytocell to expand genomics offering

Oxford Gene Technology acquires Cytocell to expand genomics offering

04-03-2014

Genetic research company Oxford Gene Technology has acquired Cambridge-based Cytocell, a leading provider…

BiotechnologyGeneticsMergers & AcquisitionsOxford Gene TechnologyUK

Abide Therapeutics in deal with Celgene on immune disorders research

03-03-2014

Privately-held Abide Therapeutics has entered into a strategic collaboration with US biotech firm Celgene…

AB101131Abide TherapeuticsBiotechnologyCelgeneImmunologicalsInflammatory diseasesLicensingMergers & Acquisitions

Ohr Pharma and Cold Spring Harbor Lab set up JV to develop trodusquemine

03-03-2014

US biotech firm Ohr Pharmaceutical and not-for-profit cancer research center Cold Spring Harbor Laboratory…

BiotechnologyDepYmedMergers & AcquisitionsOhr PharmaceuticalResearchtrodusquemine

Report: Senior life sciences executives are going dark on social media

Report: Senior life sciences executives are going dark on social media

03-03-2014

Executives are moving back to an ‘ex-directory’ world, where smaller, restricted networks are of…

BiotechnologyBoardroom

Phosphagenics appoints three new non-executive directors

03-03-2014

Australian biotechnology firm Phosphagenics has appointed biotech industry veterans Lawrence Gozlan,…

AlchemiaAustraliaBiotechnologyBoardroomOxymorphonePhosphagenics

Perrigo transfers ELND005 assets; buys OTC products

01-03-2014

Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

Israel's Clal Biotech in talks to sell Andromeda unit

28-02-2014

In an announcement to the Stock Exchange, Israeli firm Clal Biotechnology Industries said that, on February…

Andromeda BiotechBiotechnologyClal BiotechnologyDiabetesDiaPep277Mergers & AcquisitionsTeva Pharmaceutical Industries

Bayer to buy Chinese OTC/TCM drugmaker Dihon Pharma

27-02-2014

Germany’s leading pharma firm Bayer says it plans to acquire 100% of Dihon Pharmaceutical, a privately…

BayerDihon PharmaceuticalMergers & AcquisitionsPharmaceutical

Verastem acquires cancer stem cell inhibitor VS-4718 rights from Poniard

27-02-2014

US drug developer Verastem has acquired the license to VS-4718, which targets cancer stem cells, held…

BiotechnologyMergers & AcquisitionsOncologyPoniard PharmaceuticalsVerastemVS-4718

Way clear for Bayer to complete Algeta acquisition

26-02-2014

The way is now clear for Germany’s Bayer to acquire Norwegian pharmaceutical company Algeta, under…

AlgetaBayerMergers & AcquisitionsOncologyPharmaceuticalXofigo

ThromboGenics explores “strategic options” for the company

ThromboGenics explores “strategic options” for the company

24-02-2014

Belgian biotech firm ThromboGenics revealed this morning that it has retained financial advisor Morgan…

AlconBiotechnologyLicensingMergers & AcquisitionsNovartisOphthalmicsThromboGenics

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

UCB CEO succession plan ahead of next wave of product launches

UCB CEO succession plan ahead of next wave of product launches

21-02-2014

Belgium’s largest drugmaker, UCB, yesterday announced a succession plan for its chief excecutive, Roch…

BoardroomManagementPharmaceuticalUCB

Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit

20-02-2014

Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

51 to 75 of 932 results

Back to top